Literature DB >> 20042681

Ectopic T-cell specificity and absence of perforin and granzyme B alleviate neural damage in oligodendrocyte mutant mice.

Antje Kroner1, Chi Wang Ip, Johannes Thalhammer, Klaus-Armin Nave, Rudolf Martini.   

Abstract

In transgenic mice overexpressing the major myelin protein of the central nervous system, proteolipid protein, CD8+ T-lymphocytes mediate the primarily genetically caused myelin and axon damage. In the present study, we investigated the cellular and molecular mechanisms underlying this immune-related neural injury. At first, we investigated whether T-cell receptors (TCRs) are involved in these processes. For this purpose, we transferred bone marrow from mutants carrying TCRs with an ectopic specificity to ovalbumin into myelin mutant mice that also lacked normal intrinsic T-cells. T-lymphocytes with ovalbumin-specific TCRs entered the mutant central nervous system to a similar extent as T-lymphocytes from wild-type mice. However, as revealed by histology, electron microscopy and axon- and myelin-related immunocytochemistry, these T-cells did not cause neural damage in the myelin mutants, reflecting the need for specific antigen recognition by cytotoxic CD8+ T-cells. By chimerization with bone marrow from perforin- or granzyme B (Gzmb)-deficient mice, we demonstrated that absence of these cytotoxic molecules resulted in reduced neural damage in myelin mutant mice. Our study strongly suggests that pathogenetically relevant immune reactions in proteolipid protein-overexpressing mice are TCR-dependent and mediated by the classical components of CD8+ T-cell cytotoxicity, perforin, and Gzmb. These findings have high relevance with regard to our understanding of the pathogenesis of disorders primarily caused by genetically mediated oligodendropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042681      PMCID: PMC2808063          DOI: 10.2353/ajpath.2010.090722

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.

Authors:  Michael H Barnett; John W Prineas
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

2.  Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1.

Authors:  I Kobsar; M Berghoff; M Samsam; C Wessig; M Mäurer; K V Toyka; R Martini
Journal:  Brain       Date:  2003-04       Impact factor: 13.501

Review 3.  T-cell-mediated autoimmunity: novel techniques to characterize autoreactive T-cell receptors.

Authors:  Klaus Dornmair; Norbert Goebels; Hans-Ulrich Weltzien; Hartmut Wekerle; Reinhard Hohlfeld
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

4.  T cell receptor antagonist peptides induce positive selection.

Authors:  K A Hogquist; S C Jameson; W R Heath; J L Howard; M J Bevan; F R Carbone
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

Review 5.  Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases.

Authors:  Harald Neumann; Isabelle M Medana; Jan Bauer; Hans Lassmann
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

6.  Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage.

Authors:  C Readhead; A Schneider; I Griffiths; K A Nave
Journal:  Neuron       Date:  1994-03       Impact factor: 17.173

7.  Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells.

Authors:  J W Heusel; R L Wesselschmidt; S Shresta; J H Russell; T J Ley
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

8.  Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood.

Authors:  Christian Skulina; Stephan Schmidt; Klaus Dornmair; Holger Babbe; Axel Roers; Klaus Rajewsky; Hartmut Wekerle; Reinhard Hohlfeld; Norbert Goebels
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

9.  T cells compete for access to antigen-bearing antigen-presenting cells.

Authors:  R M Kedl; W A Rees; D A Hildeman; B Schaefer; T Mitchell; J Kappler; P Marrack
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

10.  Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction.

Authors:  H Babbe; A Roers; A Waisman; H Lassmann; N Goebels; R Hohlfeld; M Friese; R Schröder; M Deckert; S Schmidt; R Ravid; K Rajewsky
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

View more
  6 in total

Review 1.  Myelination and support of axonal integrity by glia.

Authors:  Klaus-Armin Nave
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

Review 2.  Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease.

Authors:  Fredrik I Gruenenfelder; Gemma Thomson; Jacques Penderis; Julia M Edgar
Journal:  J Anat       Date:  2011-03-14       Impact factor: 2.610

3.  Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis.

Authors:  Janos Groh; Kristina Berve; Rudolf Martini
Journal:  Mol Ther       Date:  2017-05-13       Impact factor: 11.454

4.  Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1β.

Authors:  Paul R Lee; Tory P Johnson; Sharmilee Gnanapavan; Gavin Giovannoni; Tongguang Wang; Joseph P Steiner; Marie Medynets; Mark J Vaal; Valerie Gartner; Avindra Nath
Journal:  J Neuroinflammation       Date:  2017-06-27       Impact factor: 8.322

5.  Teriflunomide attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutations.

Authors:  Janos Groh; Michaela Hörner; Rudolf Martini
Journal:  J Neuroinflammation       Date:  2018-07-03       Impact factor: 8.322

6.  Neuroinflammation by cytotoxic T-lymphocytes impairs retrograde axonal transport in an oligodendrocyte mutant mouse.

Authors:  Chi Wang Ip; Antje Kroner; Janos Groh; Marianne Huber; Dennis Klein; Irene Spahn; Ricarda Diem; Sarah K Williams; Klaus-Armin Nave; Julia M Edgar; Rudolf Martini
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.